Mass Tort Settlement News: Week of June 08, 2026

Mass tort settlement news this week features major developments across several high-profile litigation fronts. The week of June 8, 2026, brought significant movement in the Roundup weedkiller settlement, new opioid fund allocations, a key social media bellwether trial, and a defense verdict in talc litigation. These updates affect millions of Americans with pending or potential claims. If you believe you may be affected by any active litigation, consult a licensed attorney and visit our eligibility quiz to learn more.

Pharmaceutical Mass Tort Settlement News This Week

The Ozempic and GLP-1 litigation (MDL No. 3094) continues to expand rapidly. As of May 2026, more than 3,636 lawsuits have been filed or transferred into the consolidated MDL in the Eastern District of Pennsylvania. Meanwhile, a separate MDL has been created for GLP-1 vision loss claims involving a condition called NAION. Lawyers and doctors appeared on national television this week discussing severe gastrointestinal side effects linked to these drugs. Bellwether trials are expected in late 2026 or early 2027.

Advertisement

In addition, four companies are reportedly on the verge of settling U.S. opioid lawsuits this week. Communities continue allocating settlement funds from the nearly $60 billion in national opioid agreements. Flint, Michigan, announced plans to use $500,000 in opioid settlement funds to expand addiction care. Buncombe County, North Carolina, is seeking public input on its opioid spending plan for FY2028-2030. Albertsons reached a $774 million settlement framework earlier this year. These funds are critical for communities devastated by the opioid crisis.

Depo-Provera litigation is approaching a pivotal moment. More than 3,769 cases have been filed alleging the birth control shot causes meningioma, a type of brain tumor. Daubert hearings on expert testimony are scheduled for June 24-26, 2026. However, the first bellwether trials are not expected until December 2026. New medical guidance this week reaffirmed Tylenol safety during pregnancy, though the acetaminophen MDL remains active. For a full list of pharmaceutical cases, visit our settlement news archive.

Medical Device Lawsuit Developments

The AngioDynamics port catheter MDL (No. 3125) reached a new milestone this week. More than 357 lawsuits are now consolidated before Judge Jinsook Ohta in the Southern District of California. Bellwether case selections were due by June 5, 2026. Each side was ordered to select nine cases for an initial pool of 18. However, trials are not expected until early 2028. Plaintiffs allege the port catheters caused infections, blood clots, and device fractures.

Meanwhile, Philips issued a recall of its Trilogy Evo ventilator after serious injuries were reported. The hernia mesh litigation continues with ongoing settlement negotiations across multiple MDLs. The Bair Hugger forced-air warming device MDL (No. 2666) also remains active. Settlement discussions with Special Master James Rosenbaum continue, though no global resolution has been announced. As a result, affected patients should continue monitoring these cases through our mass tort explainer page.

Environmental Contamination Mass Tort Settlement News

The biggest mass tort settlement news in environmental litigation this week involves the Roundup weedkiller settlement. More than 100 objectors have flagged faults in Bayer’s proposed $7.25 billion settlement. Critics call it a “sweetheart deal” that violates due process rights. A legal filing claims the settlement was designed to limit cancer victims’ rights while providing $675 million in attorney fees. The settlement was transferred to the existing Roundup MDL (No. 2741) in California. A final approval hearing is set for July 9, 2026.

In AFFF and PFAS litigation, new contamination findings emerged this week. A study found widespread PFAS contamination in the Delaware River Basin. Minnesota released a plan addressing the east metro PFAS plume, though critics say it falls short. In addition, South Carolina investigators discovered toxic chemicals in crops years after farms used tainted fertilizer.

DuPont recently agreed to a $27 million settlement for water contamination in Hoosick Falls, New York. The AFFF MDL holds over 9,340 consolidated claims. For example, the Avoca Fire Department received a grant this week to replace PFAS-containing firefighting foam with safer alternatives.

📨 Get Free Mass Tort Guides Alerts

Free · No spam · Unsubscribe anytime

Metal Dynamics agreed to a settlement with the United States to reduce pollution, according to the Department of Justice. The Camp Lejeune water contamination case also remains active. Readers can compare how their state handles environmental tort claims on our tort reform by state page.

Consumer Product Litigation News

Mass tort settlement news in consumer products this week includes a defense win for Johnson & Johnson. A Los Angeles jury ruled in J&J’s favor in a talc lawsuit brought by families of three women alleging ovarian cancer. However, J&J still faces over 68,000 pending talcum powder lawsuits in MDL-2738. The company’s proposed $8 billion bankruptcy settlement was rejected in March 2026. In addition, a California judge reduced a talc verdict by removing $950 million in punitive damages earlier this year.

The social media youth addiction MDL (No. 3047) is entering a critical phase. The first federal bellwether trial begins June 15, 2026, involving Breathitt County School District in Kentucky. Nearly 2,700 cases are now pending in the MDL. Bucks County, Pennsylvania, expanded its federal lawsuit this week to include X, Roblox, and Discord alongside existing defendants.

As a result, the litigation scope continues to grow. Earlier this year, a Los Angeles jury returned a $6 million verdict against Meta and Google. Snap and TikTok both settled in January 2026. The hair relaxer litigation also remains active in MDL proceedings.

Key Deadlines and What to Watch

Several important mass tort settlement news deadlines are approaching. The first federal social media bellwether trial begins June 15, 2026, in MDL-3047. Depo-Provera Daubert hearings are scheduled for June 24-26. The Roundup settlement final approval hearing is set for July 9, 2026. Meanwhile, AngioDynamics bellwether selections will be narrowed to eight cases by December 2026.

Readers should also watch for developments in the GLP-1 litigation as trial dates solidify. The opioid settlement distribution process will continue to generate mass tort settlement news as more communities allocate funds. For the latest updates, bookmark our settlement news page and review how mass tort settlements work. Anyone who believes they may qualify for potential recovery in these cases should consult a licensed attorney promptly.

Check If You May Qualify

Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

Official Sources & Resources

For verified mass tort and MDL information:

  • JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
  • DOJ: justice.gov — settlement announcements and press releases
  • FDA: fda.gov — drug recalls, warning letters, and safety alerts
  • CDC: cdc.gov — health condition data and exposure guidelines
  • EPA: epa.gov — environmental contamination data
  • Cornell LII: law.cornell.edu — plain-English legal definitions

Content last reviewed June 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

Going through divorce too? Compare state laws at Divorce Help Guide. Affected by a recalled drug as a Medicare patient? See Medicare Cover Guide. Just diagnosed with a serious illness? Compare life insurance at Life Insure Guide. PFAS in your water? Check homeowners coverage at Home Insure Guide.